InvestorsHub Logo

pumper_stumper

07/27/20 11:50 AM

#89558 RE: mugsy4900 #89555

Isn't it great (and telling) that Bozo gets to blow another million or two this quarter on their 3rd rate diabetes testing products, and with no exaggeration, not ONE shareholder even cares or discusses quarterly results.

It's "oh we're coming up with coronavirus tests, the results for the rest of the business don't matter."

If he were smart, he take a nice payment from the DECN bank, and book a nice, even bigger loss. His shareholders will smile at him while he does it. Guess we will see 2Q results in a couple of weeks.

RealPainkiller

07/27/20 11:59 AM

#89560 RE: mugsy4900 #89555

Coronavirus (COVID-19) Update: FDA Authorizes First Diagnostic Test for Screening of People Without Known or Suspected COVID-19 Infection
Authorization is also second to allow testing of pooled samples

“FDA’s authorization of the first diagnostic test to be used for anyone, regardless of whether they are showing symptoms of COVID-19 or have other exposure risk factors, is a step toward the type of broad screening that may help enable the reopening of schools and workplaces,” said FDA Commissioner Stephen M. Hahn, M.D. “By authorizing another test for use with pooled samples, we also further help increase the possibility that patients may be able to receive results sooner, while also conserving vital testing supplies, which are under increased demand during the pandemic. Continuing to facilitate increased access to accurate and reliable tests for all Americans is critically important and the FDA continues to work around the clock with test developers to support this goal.”

https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-diagnostic-test-screening-people-without-known-or